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Abstract
Background: Negative emotional conditions contribute to the development of coronary artery
disease (CAD). Depression and anxiety are prognostic factors in patients with CAD. The aim
of our study was to investigate the association between emotional conditions and left ventricu-
lar (LV) systolic functions in CAD.
Methods: 168 patients (102 men, 66 women, mean age 66.3 ± 9.9 years) with stable angina
and multivessel disease (MVD) were included in the study. According to the LV ejection
fraction (LVEF) in echocardiography, patients were divided into two groups, the preserved group
(LVEF > 50%), and the impaired group (LVEF < 50%). The preserved group consisted of
94 patients and the impaired group consisted of 74 patients. Emotional status was evaluated
using the Hamilton Depression (HAM-D), Hamilton Anxiety (HAM-A), Beck Depression
Inventory (BDI), and Beck Anxiety Inventory (BAI) scores.
Results: The prevalence of diabetes mellitus (DM) was significantly higher in the impaired
group than in the preserved group (29.8% vs 56.8%, p < 0.01). The HAM-D, HAM-A, BAI
and BDI scores were higher in the impaired group compared to the preserved group (HAM-D:
12.1 ± 3.3 vs 14.5 ± 2.3, p = 0.03; HAM-A: 12.7 ± 3.4 vs 14.3 ± 2.2, p = 0.01; BAI: 18.6 ±
± 6.4 vs 22.1 ± 6.6, p = 0.01 and BDI: 13.9 ± 2.5 vs 17.2 ± 2.0, p = 0.002, respectively). In
multivariate analysis, BDI scores (odds ratio [OR]: 2.197, < 95% confidence interval [CI]
1.101–4.387; p = 0.026), HAM-A scores (OR: 1.912, < 95% Cl 1.092–2.974; p = 0.041) and
DM (OR: 2.610, < 95% Cl 1.313–5.183; p = 0.006) were important risk factors for LV
dysfunction in stable patients with MVD.
Conclusions: This study demonstrated that emotional status and DM are factors associated
with impaired LV systolic function in patients with stable CAD. (Cardiol J 2012; 19, 3: 249–255)
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Introduction
The relation of negative emotions such as de-
pression and anxiety with cardiovascular disease
has been reported in numerous studies [1–4]. In
patients with stable coronary artery disease (CAD),
it has been demonstrated that depression is a strong
predictor of cardiovascular events [5]. Also, anxie-
ty symptoms are associated with an increased risk
of death or myocardial infarction among patients
with CAD [6].
Multivessel CAD is an important clinical con-
dition and has a high morbidity and mortality. Im-
paired left venticular (LV) systolic function is also
an important predictor of adverse outcomes in pa-
tients with multivessel CAD [7]. Despite not hav-
ing any coronary event, one third of patients with
stable multivessel CAD have impaired LV function
[8]. The exact underlying mechanism in these pa-
tients remains unknown. Early prediction of this
clinical condition and demonstrating its preventable
causes are important.
Therefore, the main aim of this study was to
investigate the relation between depression, anxie-
ty and systolic dysfunction in patients with stable
multivessel CAD.
Methods
Study design and population
This was a prospective, cross-sectional study.
Between June 2009 and September 2010, 168 pa-
tients with stable angina and multivessel disease in
coronary angioraphy were included into the study
(102 men, 66 women, mean age 66.3 ± 9.9 years).
According to LV function in echocardiography, the
patients were divided into two groups. They were
either in the preserved group (left ventricular ejec-
tion fraction — LVEF ≥ 50%) or the impaired group
(LVEF < 50%). The preserved group consisted of
94 (36 female; mean age 65.4 ± 9.8 years) patients
and the impaired group consisted of 74 (30 female;
mean age 67.5 ± 10 years) patients. This study
complied with the Declaration of Helsinki, the pro-
tocol was approved by the Ethics Committee and the
Institutional Review Board of Erciyes University
Medical School, and informed consent was obtained
from each patient.
The exclusion criteria were known previous
myocardial infarction, any revascularization proce-
dures (percutaneous transluminal coronary angio-
plasty or coronary artery bypass grafting), unsta-
ble angina pectoris, congenital heart disease, severe
valvular heart disease, chronic renal failure, malig-
nant or known inflammatory disease, follow-up
visits or recent medical treatment for depression,
insufficient co-operation, and incomplete study
forms. Age, gender, current therapy, lipid profile,
risk factors for CAD, body mass index and biochemi-
cal measurements were recorded in all patients.
Coronary angiography
A conventional coronary angiography was perfor-
med using Philips Integris 5000 equipment (Philips
Medical Systems, Best, The Netherlands) for all
patients. Each angiogram was interpreted by two
independent cardiologists. Severity of CAD was
assessed using the Gensini scoring system which
grades narrowing of the lumens of the coronary
arteries [9]. In addition, each coronary lesion was
separately scored and added for each coronary ves-
sel to provide the vessel Syntax score, and then
combined to provide the overall patient Syntax
score as previously described using dedicated soft-
ware (Syntax score V1.0.003, Cardialysis B.V., Rot-
terdam, The Netherlands) [10, 11]. According to the
results of coronary angiography, significant steno-
sis was defined as ≥ 70% of the major coronary ar-
teries.
Echocardiography
Echocardiography was performed by two
cardiology specialists using Vivid 7 instruments
(GE Medical Systems, Milwaukee, WI, USA), with
a 2.5-MHz transducer and harmonic imaging in the
Cardiology Department’s echocardiography labora-
tory. According to the recommendations of the
American Society of Echocardiography [12], left
ventricular systolic (LVSD) and diastolic diameters
(LVDD) were measured by M-mode echocardio-
graphy. The LVEF was assessed using the modi-
fied biplane Simpson’s method.
Psychological tests
Psychological interviews were performed by
a psychiatrist. The severity of depression and anxie-
ty were assessed using the Hamilton Depression
(HAM-D), Hamilton Anxiety (HAM-A), Beck De-
pression Inventory (BDI), and Beck Anxiety Inven-
tory (BAI) as psychological symptoms scales [13–
–17]. During the psychological assessment, neither
the psychiatrist nor the patient were aware of the
clinical status or angiographic results. BDI-II is
a 21-item scale developed by Beck et al. [16] that
is widely used to measure the severity of depres-
sion. Each item was scored from 0 to 3, in increas-
ing order of severity. The scores for each of these
21 items were totaled at the end of the psychological
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evaluation. Accuracy and reliability studies of the BDI
have been conducted by Hisli, who accepted a score
of 17 or above as indicative of major depression in the
Turkish population; we accepted the same value as
our indicator of major depression [18]. To distinguish
patients with depression, Carney et al. [19] used a BDI
score equal to or greater than 10, which revealed
a moderate sensitivity (78%) and specificity (90%).
The BAI is applied in a manner similar to that of the
BDI. The validity and reliability of the BAI have been
studied in the Turkish population by Ulusoy et al. [17].
After completion of the symptom scales and tabula-
tion of the results, we performed a clinical psychiat-
ric interview for each patient.
Statistical analysis
Continuous variables were tested for normal
distribution by the Kolmogorov-Smirnov test. We
report continuous data as mean and standard devia-
tion or median. We compared continuous variables
using Student t-test or Mann-Whitney U test be-
tween groups. Categorical variables were summa-
rized as percentages and compared with the c2 test.
The effects of different variables on left ventricu-
lar dysfunction were calculated in univariate analy-
sis for each. The variables for which the unadjust-
ed p value was < 0.10 in logistic regression analy-
sis were identified as potential risk markers and
included in the full model. We reduced the model
by using backward elimination multivariate logis-
tic regression analyses and we eliminated potential
risk markers by using likelihood ratio tests. A two-
sided p < 0.05 was considered as significant and
confidence interval (CI) was 95%. All statistical
analyses were performed using SPSS version 15
(SPSS, Inc., Chicago, IL, USA).
Results
Table 1 shows the baseline demographic and
biochemical characteristics of patients in both
groups. Except for the prevalence of diabetes mel-
litus (DM), the other properties were similar in the
two groups. The prevalence of DM was significant-
ly higher in the impaired group than in the pre-
served group (56% vs 29%, p < 0.01).
The mean LVEF was significantly higher in
the preserved group than in the impaired group
Table 1. Baseline characteristics of patients in groups.
Preserved group (n = 94) Impaired group (n = 74) P
Age [years] 65.4 ± 9.8 67.5 ± 10 0.1
Gender [female/male] 36/58 30/44 0.7
Body mass index [kg/m2] 25.4 ± 2.8 26.0 ± 2.8 0.1
Smoking 32 (34%) 22 (29.7%) 0.5
Hypertension 64 (68.1%) 46 (62.2%) 0.4
Hypercholesterolemia 36 (38.3%) 22 (29.7%) 0.2
Diabetes mellitus 28 (29.8%) 42 (56.8%) 0.01
Blood pressure [mm Hg]
Systolic 136.0 ± 17.3 140.2 ± 16 0.1
Diastolic 77.7 ± 14.6 81.4 ± 15 0.1
Heart rate [bpm] 81.9 ± 13.2 79.5 ± 16.1 0.3
Lipid profile [mg/dL]
Total cholesterol 173.6 ± 37.4 181.8 ± 39.8 0.1
HDL-cholesterol 35.6 ± 6.9 34.7 ± 6.3 0.4
LDL-cholesterol 121.5 ± 28.7 126.0 ± 30.1 0.3
Plasma triglycerides 126.2 ± 68.6 117.5 ± 41.9 0.2
Current therapy
Aspirin 34 (36.2%) 24 (32.4%) 0.6
Beta-blockers 20 (21.3%) 18 (24.3%) 0.6
ACE-I/ARB 50 (53.2%) 34 (45.9%) 0.3
Nitrates 8 (8.5%) 8 (10.8%) 0.6
Statins 40 (42.6%) 30 (40.5%) 0.7
Ca-antagonists 30 (31.9%) 18 (24.3%) 0.2
Data is expressed as mean ± SD or percentage; p < 0.05 accepted as statistically significant; ACE-I — angiotensin converting enzyme inhibitor;
ARB — angiotensin receptor blocker
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(58.1 ± 6.3 vs 29.0 ± 5.4, p < 0.01). The mean
Gensini and Syntax scores were not significantly
different between groups. Table 2 shows echocar-
diographic and angiographic findings.
Figures 1 and 2 show the results of the anxi-
ety and depression scores in the groups. The anxi-
ety scores were significantly higher in patients with
reduced LV systolic function compared to patients
with preserved LV systolic function (HAM-A: 14.3 ±
± 2.2 vs 12.7 ± 3.4, p = 0.01, BAI: 22.1 ± 6.6 vs
18.6 ± 6.4, p = 0.01, respectively). Also, patients
in the impaired group had higher HAM-D and BDI
scores (HAM-D: 14.5 ± 2.3 vs 12.1 ± 3.3, p = 0.01,
BDI: 17.2 ± 2.0 vs 13.9 ± 2.5, p = 0.002, respec-
tively). The presence of major depression in pa-
tients were similar between preserved and impaired
groups (20.2% vs 21.6%, p = 0.87).
In the groups, some of the variables that can
affect LV function were significantly different be-
tween groups. Thus, the effects of multiple varia-
bles on the LV function were analyzed with univaria-
te and multivariate logistic regression analyses.
The variables for which the unadjusted p value was
< 0.10 in univariate analysis were identified as po-
Table 2. Echocardiographic parameters of all patients in groups.
Preserved  group (n = 94) Impaired group (n = 74) P
LVEDD [mm] 51.2 ± 4.1 63.1 ± 6.7 < 0.01
LVESD [mm] 33.2 ± 4.0 48.9 ± 7.8 < 0.01
IVS thickness [mm] 11.8 ± 1.9 10.9 ± 1.4 0.01
PW thickness [mm] 11.2 ± 1.5 10.6 ± 1.0 0.03
LVEF [%] 58.1 ± 6.3 29.0 ± 5.4 < 0.01
LV mass [g] 160.1 ± 31.4 154.5 ± 32.8 0.2
Left atrial size [mm] 34.5 ± 4.7 41.4 ± 3.3 < 0.01
RVEDD [mm] 36.1 ± 4.0 39.5 ± 2.7 < 0.01
sPAP [mm Hg] 32.4 ± 10.4 38.0 ± 13.3 0.03
E/A ratio 0.88 ± 0.21 0.96 ± 0.26 0.08
Gensini score 84.5 ± 29.2 89.6 ± 21.7 0.1
Syntax score 27.7 ± 5.4 28.6 ± 4.9 0.2
Data is expressed as mean ± SD; LV — left ventricular; LVEDD — LV end-diastolic diameters; LVESD — LV end-systolic diameters; IVS — interventicular
septum; PW — posterior wall; LVEF — LV ejection fraction; RVEDD — right ventricular end-diastolic diameters; sPAP — systolic pulmonary artery
pressure; p < 0.05 is accepted as statistically significant
Figure 1. Anxiety test scores in preserved and impaired
groups; HAM-A — Hamilton Anxiety scales; BAI — Beck
Anxiety Inventory; p < 0.05 accepted as significant;
*p = 0.01.
Figure 2. Depression test scores in preserved and im-
paired groups; HAM-D — Hamilton Depression scale;
BDI — Beck Depression Inventory scale; p < 0.05 ac-
cepted as significant; *p = 0.01; #p = 0.002.
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tential risk markers for LVEF and included in the
full model. In multivariate analysis, BDI scores
(odds ratio [OR]: 2.197, 95% confidence interval
[CI] 1.101–4.387; p = 0.026), HAM-A scores (OR:
1.912, 95% Cl 1.092–2.974; p = 0.041) and DM (OR:
2.610, 95% Cl 1.313–5.183; p = 0.006) were impor-
tant risk factors for LV dysfunction in stable pa-
tients with multivessel disease (Table 3).
Discussion
Negative emotional status has unfavorable ef-
fects on cardiovascular and other systems. In this
study, we demonstrated an association between
negative emotional status and LV function in pa-
tients with stable CAD. Anxiety, depression and
DM were found to be independently associated with
impaired LV systolic function in our stable, multi-
vessel disease patients.
Previous studies have reported an association
between depression and systolic dysfunction [14,
16], but some studies have not found a relation be-
tween depression and LV systolic functions [20]. On
the other hand, one third of patients with stable
angina pectoris have impaired LV function [8]. The
exact underlying mechanism in these patients re-
mains unknown.
The main aim of our study was to investigate
the relation between depression and anxiety and
systolic dysfunction in patients with stable CAD.
Our results showed that patients with systolic dys-
function had higher HAM-D and BDI scores com-
pared to patients with normal systolic function.
Several hypotheses have been put forward to
explain the association between symptoms of de-
pression and CAD, including increased platelet
reactivity, endothelial dysfunction, decreased variabili-
ty of heart rate, and accelerated atherogenesis [21].
However, the most plausible explanation of systo-
lic dysfunction in our patients was microvascular
dysfunction due to depression and anxiety that was
causing myocardial ischemia. Our patients had sta-
ble clinical status.
The important question is whether depression
causes myocardial ischemia in stable patients. Jiang
et al. [22] demonstrated that stable patients with
mild to moderate depressive symptoms are more
likely to exhibit myocardial ischemia. This study
suggests that silent myocardial ischemia may be one
of the most important mechanisms for systolic dys-
function in stable patients who have multivessel
disease. Comorbid depression in patients with
a history of CAD is frequently undiagnosed and/or
untreated in spite of these negative clinical impli-
cations [23, 24]. Therefore, all clinicians should be
aware of a diagnosis of depression.
Previous studies have identified the impor-
tance of impaired myocardial blood flow, particularly
in the microvascular bed, in relation to ischemia
induced by mental stress [25]. A high predisposi-
tion to anxiety could reflect a chronic stress condi-
tion with long-term high anxiety levels [26]. There-
fore, the relation between long-term anxiety and
myocardial ischemia has great clinical importance.
In this study, anxiety may affect systolic function
due to ischemia.
In previous studies, depression and anxiety sco-
res have been elevated in the presence of CAD [27].
In patients with CAD, the prevalence of depression
is around 20–40%, and depression is associated with
significant cardiac morbidity and mortality [28].
CAD may be a cause of psychosocial disorders.
Table 3. Effects of various variables on left ventricular systolic dysfunction in univariate and
multivariate logistic regression analyses.
Variables Unadjusted OR 95% CI P Adjusted OR 95% CI P
Age 1.023 0.991–1.055 0.160
Gender 0.910 0.448–1.698 0.768
Hypertension 0.970 0.776–1.460 0.423
Diabetes mellitus 3.094 1.635–5.855 0.001 2.610 1.313–5.183 0.006
Smoking 0.820 0.625–1.580 0.553
LDL-cholesterol 1.005 0.995–1.016 0.321
Gensini score 1.037 0.997–1.100 0.235
Syntax score 1.007 0.996–1.019 0.214
BDI 2.747 1.450–5.194 0.002 2.197 1.101–4.387 0.026
HAM-A 1.921 1.121–3.244 0.011 1.912 1.092–2.974 0.041
OR — odds ratio; CI — confidence interval; BDI — Beck Depression Inventory; HAM-A — Hamilton Anxiety scale
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Actually, the relationship between depression
and cardiac disease is both complex and bidirectio-
nal. Additionally, a significant association was found
between depression, anxiety and DM. In a previ-
ous study, diabetic patients scored significantly
higher in anxiety and depression scores. Murrel et
al. [29] reported the prevelance of depression in
a diabetic population to be 13.4% in male and 25.4%
in female patients.
On the other hand, clinical depression and ele-
vated levels of depressive symptoms have been
linked to inflammation in both younger and older
community-dwelling persons [30, 31]. Vaccarino et
al. [32] demonstrated that a similar association was
observed in patients with a diagnosis of major de-
pression during an active depressive episode. Giv-
en the well-established role of inflammation in the
pathogenesis and risk prediction of CAD [33], it is
possible that inflammation modulates the relation-
ship between depression and CAD. Psychological
stress and depression may induce inflammation
through a number of mechanisms via sympathetic
nervous system activation [34]. One of these pos-
sible mechanisms is that stress activates the tran-
scription factor nuclear factor kappa B in peripher-
al blood mononuclear cells, an effect that is depen-
dent on norepinephrine and one that is abolished
by alpha 1-adrenoceptor blockade [35]. In addition,
beta adrenoceptor stimulation increases gene ex-
pression and protein production of several inflam-
matory cytokines [36]. Thus, inflammation plays
a role in the pathogenesis of depression.
In previous studies, depression was frequent-
ly found in diabetics [37]. Diabetes mellitus may
place patients at risk for a depressive disorder
through a biological mechanism linking the meta-
bolic changes of this disease to changes in brain
structure and function [38]. Vural et al. [39] de-
monstrated an association between DM and higher
HAM-D and HAM-A scores. McIntyre et al. [40]
found that the use of serotoninergic antidepressants
(e.g. fluoxetine) to treat depression in diabetics re-
duced hyperglycemia, normalized glucose homeosta-
sis, and increased insulin sensitivity. Therefore, the
relationship between depression and DM is a bidi-
rectional phenomenon.
We found that depression and anxiety scores
were, surprisingly, significantly higher in patients
who had reduced LV systolic function and DM. We
believe that patients with DM and reduced LV sys-
tolic function should be carefully followed up for
diagnosis of depression and anxiety disorder, the
treatment of which may improve the prognosis of
CAD.
Limitations of the study
We cannot exclude the effect of unmeasured
third variables, such as other psychological parame-
ters. Also, this study was a cross-sectional study.
It would be better to follow the changes in depres-
sion and anxiety scores in these patients and the
effect of these changes on blood pressure, lipid levels,
blood glucose, and the course of CAD. Additionally,
because our study’s most important limitation was
the small number of patients, it was difficult to draw
definitive conclusions from the results. Therefore,
large, long-term follow-up studies are needed.
Conclusions
This study demonstrated a significant relation-
ship between depression and anxiety scores and
reduced LV systolic function and DM in patients
with multivessel coronary disease. These findings
suggest that depression and anxiety disorders may
contribute to the deterioration of LV systolic func-
tion in patients with multivessel coronary disease
and stable angina. Therefore, depression and anxie-
ty disorders can be considered as preventive inter-
vention and a secondary therapeutic option for
multivessel disease and stable angina.
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